RxDoctor Payments Data

Haley Gardner

Family · Vero Beach, FLNPI 1265139463

Payments from drug & device makers

$769in general payments, 2019–2025

Across 37 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$148
  • Lilly USA, LLC$122
  • Exact Sciences$79
  • GSK$67
  • Eisai Inc.$63
  • Takeda Pharmaceuticals U.S.A., Inc.$61
  • plus $228 from 8 others

What the payments were for

  • Food & beverage$769100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$769 in reported general payments places this provider in the 65th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$101,264
Medicare patients
430
Services billed
1,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$56,282
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$47,440
EliquisApixaban34$42,334
MounjaroTirzepatide38$41,669
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$14,207
JardianceEmpagliflozin12$14,138
FarxigaDapagliflozin Propanediol14$13,040
TrulicityDulaglutide12$11,722
GemtesaVibegron13$10,973
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,350
Lagevrio (Eua)Molnupiravir19$6,166
Omeprazole111$2,835
Albuterol Sulfate HfaAlbuterol Sulfate133$2,825
Atorvastatin Calcium283$2,603
Rosuvastatin Calcium197$2,515

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$148$56,28236 claims
Lilly USA, LLCMounjaro, Trulicity$122$53,39150 claims
GSKTrelegy Ellipta$67$47,44041 claims
PfizerEliquis, Paxlovid$25$43,78858 claims
AstraZenecaFarxiga, Breztri Aerosphere$41$20,39026 claims
MerckLagevrio (Eua)$13$6,16619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 14,618 family providers in Florida.

Other family in Vero Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →